BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29944858)

  • 1. Altered glutamate response and calcium dynamics in iPSC-derived striatal neurons from XDP patients.
    Capetian P; Stanslowsky N; Bernhardi E; Grütz K; Domingo A; Brüggemann N; Naujock M; Seibler P; Klein C; Wegner F
    Exp Neurol; 2018 Oct; 308():47-58. PubMed ID: 29944858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased N-TAF1 expression in X-linked dystonia-parkinsonism patient-specific neural stem cells.
    Ito N; Hendriks WT; Dhakal J; Vaine CA; Liu C; Shin D; Shin K; Wakabayashi-Ito N; Dy M; Multhaupt-Buell T; Sharma N; Breakefield XO; Bragg DC
    Dis Model Mech; 2016 Apr; 9(4):451-62. PubMed ID: 26769797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome editing in induced pluripotent stem cells rescues TAF1 levels in X-linked dystonia-parkinsonism.
    Rakovic A; Domingo A; Grütz K; Kulikovskaja L; Capetian P; Cowley SA; Lenz I; Brüggemann N; Rosales R; Jamora D; Rolfs A; Seibler P; Westenberger A; König I; Klein C
    Mov Disord; 2018 Jul; 33(7):1108-1118. PubMed ID: 30153385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-linked Dystonia-Parkinsonism patient cells exhibit altered signaling via nuclear factor-kappa B.
    Vaine CA; Shin D; Liu C; Hendriks WT; Dhakal J; Shin K; Sharma N; Bragg DC
    Neurobiol Dis; 2017 Apr; 100():108-118. PubMed ID: 28017799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analysis of X-linked dystonia parkinsonism disease striatal neurons reveals altered RNA metabolism and splicing.
    Tshilenge KT; Bons J; Aguirre CG; Geronimo-Olvera C; Shah S; Rose J; Gerencser AA; Mak SK; Ehrlich ME; Bragg DC; Schilling B; Ellerby LM
    Neurobiol Dis; 2024 Jan; 190():106367. PubMed ID: 38042508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and Molecular Properties of DYT-SGCE Myoclonus-Dystonia Patient-Derived Striatal Medium Spiny Neurons.
    Kutschenko A; Staege S; Grütz K; Glaß H; Kalmbach N; Gschwendtberger T; Henkel LM; Heine J; Grünewald A; Hermann A; Seibler P; Wegner F
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased calcium flux in Niemann-Pick type C1 patient-specific iPSC-derived neurons due to higher amount of calcium-impermeable AMPA receptors.
    Rabenstein M; Peter F; Joost S; Trilck M; Rolfs A; Frech MJ
    Mol Cell Neurosci; 2017 Sep; 83():27-36. PubMed ID: 28666962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal dysfunction in X-linked dystonia-parkinsonism is associated with disease progression.
    Brüggemann N; Rosales RL; Waugh JL; Blood AJ; Domingo A; Heldmann M; Jamora RD; Münchau A; Münte TF; Lee LV; Buchmann I; Klein C
    Eur J Neurol; 2017 May; 24(5):680-686. PubMed ID: 28236370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroanatomical changes extend beyond striatal atrophy in X-linked dystonia parkinsonism.
    Brüggemann N; Heldmann M; Klein C; Domingo A; Rasche D; Tronnier V; Rosales RL; Jamora RD; Lee LV; Münte TF
    Parkinsonism Relat Disord; 2016 Oct; 31():91-97. PubMed ID: 27481033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting the Causal Mechanism of X-Linked Dystonia-Parkinsonism by Integrating Genome and Transcriptome Assembly.
    Aneichyk T; Hendriks WT; Yadav R; Shin D; Gao D; Vaine CA; Collins RL; Domingo A; Currall B; Stortchevoi A; Multhaupt-Buell T; Penney EB; Cruz L; Dhakal J; Brand H; Hanscom C; Antolik C; Dy M; Ragavendran A; Underwood J; Cantsilieris S; Munson KM; Eichler EE; Acuña P; Go C; Jamora RDG; Rosales RL; Church DM; Williams SR; Garcia S; Klein C; Müller U; Wilhelmsen KC; Timmers HTM; Sapir Y; Wainger BJ; Henderson D; Ito N; Weisenfeld N; Jaffe D; Sharma N; Breakefield XO; Ozelius LJ; Bragg DC; Talkowski ME
    Cell; 2018 Feb; 172(5):897-909.e21. PubMed ID: 29474918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eye movement deficits in X-linked dystonia-parkinsonism are related to striatal degeneration.
    Sprenger A; Hanssen H; Hagedorn I; Prasuhn J; Rosales RL; Jamora RDG; Diesta CC; Domingo A; Klein C; Brüggemann N; Helmchen C
    Parkinsonism Relat Disord; 2019 Apr; 61():170-178. PubMed ID: 30352750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroinflammation and histone H3 citrullination are increased in X-linked Dystonia Parkinsonism post-mortem prefrontal cortex.
    Petrozziello T; Mills AN; Vaine CA; Penney EB; Fernandez-Cerado C; Legarda GPA; Velasco-Andrada MS; Acuña PJ; Ang MA; Muñoz EL; Diesta CCE; Macalintal-Canlas R; Acuña-Sunshine G; Ozelius LJ; Sharma N; Bragg DC; Sadri-Vakili G
    Neurobiol Dis; 2020 Oct; 144():105032. PubMed ID: 32739252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroimaging and neuropathology studies of X-linked dystonia parkinsonism.
    Arasaratnam CJ; Singh-Bains MK; Waldvogel HJ; Faull RLM
    Neurobiol Dis; 2021 Jan; 148():105186. PubMed ID: 33227492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological and molecular properties of AMPA/Kainate receptors expressed by striatal medium spiny neurons.
    Stefani A; Chen Q; Flores-Hernandez J; Jiao Y; Reiner A; Surmeier DJ
    Dev Neurosci; 1998; 20(2-3):242-52. PubMed ID: 9691198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A hexanucleotide repeat modifies expressivity of X-linked dystonia parkinsonism.
    Westenberger A; Reyes CJ; Saranza G; Dobricic V; Hanssen H; Domingo A; Laabs BH; Schaake S; Pozojevic J; Rakovic A; Grütz K; Begemann K; Walter U; Dressler D; Bauer P; Rolfs A; Münchau A; Kaiser FJ; Ozelius LJ; Jamora RD; Rosales RL; Diesta CCE; Lohmann K; König IR; Brüggemann N; Klein C
    Ann Neurol; 2019 Jun; 85(6):812-822. PubMed ID: 30973967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive profile of patients with X-linked dystonia-parkinsonism.
    Jamora RDG; Suratos CTR; Bautista JEC; Ramiro GMI; Westenberger A; Klein C; Ledesma LK
    J Neural Transm (Vienna); 2021 May; 128(5):671-678. PubMed ID: 33638704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological Phenotype and Genetics of X-Linked Dystonia-Parkinsonism (XDP; DYT3; Lubag).
    Kawarai T; Morigaki R; Kaji R; Goto S
    Brain Sci; 2017 Jun; 7(7):. PubMed ID: 28672841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promise and challenges of dystonia brain banking: establishing a human tissue repository for studies of X-Linked Dystonia-Parkinsonism.
    Fernandez-Cerado C; Legarda GP; Velasco-Andrada MS; Aguil A; Ganza-Bautista NG; Lagarde JBB; Soria J; Jamora RDG; Acuña PJ; Vanderburg C; Sapp E; DiFiglia M; Murcar MG; Campion L; Ozelius LJ; Alessi AK; Singh-Bains MK; Waldvogel HJ; Faull RLM; Macalintal-Canlas R; Muñoz EL; Penney EB; Ang MA; Diesta CCE; Bragg DC; Acuña-Sunshine G
    J Neural Transm (Vienna); 2021 Apr; 128(4):575-587. PubMed ID: 33439365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons.
    Cepeda C; André VM; Yamazaki I; Wu N; Kleiman-Weiner M; Levine MS
    Eur J Neurosci; 2008 Feb; 27(3):671-82. PubMed ID: 18279319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential localization of the GluR1 and GluR2 subunits of the AMPA-type glutamate receptor among striatal neuron types in rats.
    Deng YP; Xie JP; Wang HB; Lei WL; Chen Q; Reiner A
    J Chem Neuroanat; 2007 Jul; 33(4):167-92. PubMed ID: 17446041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.